Intarcia Therapeutics

Discussion in 'Intarcia Therapeutics' started by anonymous, Mar 31, 2017 at 10:22 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    LOL - insider PR pimping? Yep like the glassdoor dot con's positive reviews, huh?
     

  2. anonymous

    anonymous Guest

    It's race to the bottom for the GLP-1 drug market place in rather crowded arena with those who discount their drug the most may win the fleeting market share.

    Payers MAY authorize the pricey GLP-1 implant and surgical procedure IF it is approved for those who cannot swallow pills or afraid of needles or something with no doubt big co-pay. Tiny costly niche at best...
     
  3. anonymous

    anonymous Guest

    LOL - insider I presume? Alas if you can convince the payers, patients and endocrinologists...
     
  4. anonymous

    anonymous Guest

    Dead unicorn in making with bogus claim of largest private biotech. Heard they have been around for over 20 yrs and never launched a product. Any news on these guys raising yet another round of $?

    As for those interested in joining the ranks of dying unicorn - question their speels beyond fantasy gobbledygook and ask yourself what will you do when they flame out of the gate and find yourself on the ranks of unemployed line.
     
  5. anonymous

    anonymous Guest

    Best case scenario is approval by Q4 and worst case scenario is CRL (complete response letter) which will push out the approval to 6 to 24 months (if new trial is required). Oh wait patent expires bout same time.

    Do I hear that giant sucking sound of cash being flushed down the toilet and down rounds around the corner?
     
  6. anonymous

    anonymous Guest

    Whoooooa Come Halloweeeeeen Spoooooky Exenatide Generics take over..........
    • Teva has reached an agreement with AstraZeneca allowing it to market a generic copy of the injectable diabetes drug Byetta by late next year, the Israeli drugmaker said Thursday.
    • Under the deal, Teva will be able to commercialize Byetta in the U.S. starting on October 15, 2017, although a statement alluded to certain circumstances by which sales could begin earlier.
    • While a generic competitor will crimp sales, AstraZeneca has already switched its focus to the extended release version of the GLP-1 drug, called Bydureon.
     
  7. anonymous

    anonymous Guest

    Great news for the patients even if twice daily administration. Expect pricing pressures on the other weekly and especially daily stalwart Victoza. Yep indeed race to the bottom with the payers rule the roost.

    And Intarcia boys in Boston think they are going to rule from the roost with rip-off price implant pump.
     
  8. anonymous

    anonymous Guest

    It's amazing how recruiters have no clue about salary, bonus, company car or car allowance, sign on bonus etc. absolutely nothing. Wtf???!
     
  9. anonymous

    anonymous Guest

    The word on the street is unofficial hiring freeze until they raise more money. It dawned upon these arrogant pricks that it takes shit load of money to build up the organization. They are just collecting and ranking resumes by each region by clueless temp recruiters. Also heard uncertainty is becoming more obvious at the penthouse HQ.
     
  10. anonymous

    anonymous Guest

    Word in the test tube is impurities above acceptable threshold.
     
  11. anonymous

    anonymous Guest

    They monkeyed with different test methods hoping the impurities would disappear but no dice. Good luck explaining that to FDA during PAI.
     
  12. anonymous

    anonymous Guest

    Intarcia interviewers at the home office are awful. They think they are better than EVERYONE. My recruiter had me so excited for this "opportunity". What a shame.
     
  13. anonymous

    anonymous Guest

    Is this a flat out fraud ? Recruiter told me they are going to prevent AIDs with the pump. Yeah right.
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

    My experience as well interviewing..very condescending, better than you attitude...in my experience that leads to a disasterous launch.
     
  16. anonymous

    anonymous Guest

    Children, our leadership is the strongest ever assembled to tackle a major challenge to humanity in the history of the world. No doubt you felt small in our presence. We are beyond good, beyond fantastic, we are the ultimate. Rome had Emperors, France had Napolepon, Intarcia has Graves
     
  17. anonymous

    anonymous Guest

    Correctamundo. CEO Graves hoodwinked Bill Gates and Bill stupidly went hook line and sinker for LIES - not even Ph I mind you.

    PT Barnum was right - suckers born every minute!
     
  18. anonymous

    anonymous Guest

    Did you have telephone interview or visit to the Boston HQ? Yep they are real arrogant pricks all right when I approached them at ADA conference. Those fuckers will be humbled sooner than later.
     
  19. anonymous

    anonymous Guest

    Home office.
     
  20. anonymous

    anonymous Guest

    Yeah at ADA was very hard to have a reasonable conversation about Bydureon or Bayetta - keep insisting that uptake would be faster than any other drug in diabetes because pumps cure compliance